Cervical phIGFBP-1 in the evaluation of the risk of preterm delivery

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 2, 2007, Pages 151-155

  Paternoster, Delia Maria ^a   Muresan, Dana ^a   Vitulo, Anna ^a   Serena, Andrea ^a   Battagliarin, Giuseppe ^a   Dell'Avanzo, Marinella ^b   Nicolini, Umberto ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Asymptomatic; Partus test; Phosphorylated insulin like growth factor binding protein 1; Preterm delivery; Symptomatic

Indexed keywords

FIBRONECTIN; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALIDITY; PREMATURE LABOR; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CYTOLOGY; VAGINA SECRETION;

ADULT; BIOLOGICAL MARKERS; CERVIX UTERI; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDIES; PROTEIN ISOFORMS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33846976716     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340600935730     Document Type: Article

References (24)

1. Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad A, Das A, et al. The preterm prediction study: toward a multiple marker test for spontaneous preterm birth. Am J Obstet Gynecol. 2001;185:643-51.
2. Creasy RK. Preterm birth prevention: where are we? Am J Obstet Gynecol. 1993;168:1223-30.
3. Bibby E, Stewart A. The epidemiology of preterm birth. Neuro Endocrinol Lett. 2004;25(Suppl 1):43-7.
4. Haram K, Mortensen JHS, Wollen AL. Preterm delivery: an overview. Acta Obstet Gynecol Scand. 2003;82:687-704.
5. Zlatnik FJ, Yankowitz J, Whitham J, Burmeister LF. Vaginal ultrasound as an adjunct to cervical digital examination in women at risk of early delivery. Gynecol Obstet Invest. 2001;51(1):12-6.
6. Colombo DF, Iams JD. Cervical length and preterm labor. Clin Obstet Gynecol. 2000;43:735-45.
7. Heath VC, Sounthall TR, Souka AP, Elisseou A, Nicolaides KH. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol. 1998;12(5):312-7.
8. Leeson SC, Maresh MJ, Martindale EA, Mahmood T, Moutune A, Hawkes N, et al. Detection of fetal fibronectin as predictor of preterm delivery in high risk asymptomatic pregnancies. Br J Obstet Gynecol. 1996;103:48-53.
9. Leeson SC, Maesh MJA. Fibronectin: a predictor of preterm delivery? Br J Obstet Gynecol. 1994;71:5-10.
10. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 1991;325:669-74.
11. Luzzi V, Hankins K, Gronowski AM. Accuracy of the rapid fetal fibronectin TLi System in predicting preterm delivery. Clin Chem. 2003;49:501-2.
12. Faron G, Boulvain M, Irion O, Bernard PM, Fraser WD. Prediction of preterm delivery by fetal fibronectin: a meta-analysis. Obstet Gynecol. 1998;92:153-8.
13. Leitich H, Kaider A. Fetal fibronectin - how useful is it in the prediction of preterm birth? Br J Obstet Gynecol. 2003;110(Suppl 20):66-70.
14. Grehangen JB, Van Wagoner J, Dudley D, Hunter C, Mitchel M, Logsdon V, et al. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol. 1996;4(1):1054-6.
15. Bang P, Vestgren M, Schwander J, Blum WF, Rosenfeld RG, Stangenberg M. Ontogeny of insulin-like growth factor binding protein-1,-2 and -3: quantitative measurements by radioimmunoassay in human fetal serum. Pediatr Res. 1994;36(4):528-36.
16. Kekki M, Kurki T, Kärkkäinen T, Hilesmaa V, Paavonen J, Rutanen E-M. Insulin like growth factor binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand. 2001;80:546-51.
17. Lembet A, Eroglu D, Ergin T, Kuscu E, Zeyneloglu H, Batioglu S, et al. New rapid bed-side test to predict preterm delivery: phosphorylated insulin-like growth factor binding protein-1 in cervical secretion. Acta Obstet Gynecol Scand. 2002;81:706-12.
18. Kurkinen-Räty M, Ruokonen A, Vuopala S, Koskela M, Rutaten E-M, Kärkkäinen T, et al. Combination of cervical interleukin-6 and -8, phosphorylated insulin-like growth factor-binding protein-1 and transvaginal cervical ultrasonography in assessment of the risk of preterm birth. Br J Obstet Gynecol. 2001;108:875-88.
19. Kekki M, Kurki T, Pavonen J, Rutanen E-M. Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis. Lancet. 1999;353:1494.
20. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD. Common complications of pregnancy. In: Williams Obstetrics, 21st edition. New York: McGraw-Hill, 2001 cap. VII:689-7.
21. Paternoster DM, Stella A, Gerace P, Manganelli F, Plebani M, Snijders D, et al. Biochemical markers for the prediction of spontaneous pre-term birth. Int J Gynecol Obstet. 2002;79:123-9.
22. Akercan F, Kazandi M, Sendag F, Cirpan T, Mgoyi L, Terek MC, et al. Value of cervical phosphorylated insulinlike growth factor binding protein-1 in the prediction of preterm labor. J Reprod Med. 2004;49:368-72.
23. Tekesin I, Marek S, Hellmeyer L, Reitz D, Schmidt S. Assessment of rapid fetal fibronectin in predicting preterm delivery. Obstet Gynecol. 2005;105:280-4.
24. Rutanen E-M. Insulin-like growth factors in obstetrics. Curr Opin Gynecol. 2000;12:163-8.